Origen de la red de primer grado Matthew J. Pietras.
| Entidad | Tipo de entidad | Industria | |
|---|---|---|---|
| Subsidiary | Biotechnology | 11 | |
| Public Company | Medical Specialties | 1 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Matthew J. Pietras a través de su red personal
| Empresa | Sector | Personas relacionadas | Puesto principal |
|---|---|---|---|
MedImmune LLC
 MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Investor Relations Contact Corporate Officer/Principal | |
| PHASEBIO PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
MedImmune Ventures, Inc.
 MedImmune Ventures, Inc. Investment ManagersFinance MedImmune Ventures, Inc. ( Medimmune Ventures) is a venture capital firm founded in 2002 by Ron Laufer, Wayne Hockmeyer and David Mott . The firm is headquartered in Gaithersburg, Maryland. | Investment Managers | Corporate Officer/Principal | |
Cerapedics, Inc.
 Cerapedics, Inc. Pharmaceuticals: MajorHealth Technology Cerapedics, Inc. engaged in the provision of developing and commercializing novel osteobiologic products. It offers i-FACTOR Bone Graft, an advanced biologic that supported with level I evidence, and provides benefit ratio. The company was founded by Andrew J. Tofe and is headquartered in Westminster, CO. | Pharmaceuticals: Major | Director/Board Member | |
| WUXI PHARMATECH (CAYMAN) INC. (ADR) | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member Director/Board Member | |
| Rotman School of Management | College/University | Masters Business Admin | |
| HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | College/University | Doctorate Degree | |
| Massachusetts Institute of Technology | College/University | Undergraduate Degree | |
| The University of Texas at Austin | College/University | Doctorate Degree | |
| The Johns Hopkins University | College/University | Graduate Degree | |
| Juniata College | College/University | Undergraduate Degree | |
| University of Toronto | College/University | Graduate Degree | |
| Universität zu Köln | College/University | Doctorate Degree | |
| The University of North Carolina at Wilmington | College/University | Undergraduate Degree | |
| WUXI APPTEC CO., LTD. | Pharmaceuticals: Major | Chief Investment Officer Director/Board Member Director/Board Member | |
General Atlantic Asia Ltd.
 General Atlantic Asia Ltd. Investment ManagersFinance General Atlantic Asia Ltd. is a Private Equity/Venture Capital firm, a subsidiary of General Atlantic LLC founded in 2007. General Atlantic Asia Ltd. is headquartered in Hong Kong. | Investment Managers | Director of Investments Private Equity Analyst | |
| GAN & LEE PHARMACEUTICALS. | Pharmaceuticals: Major | Director/Board Member | |
| AVALO THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Entegra Systems, Inc.
 Entegra Systems, Inc. Information Technology ServicesTechnology Services Entegra Systems, Inc. develops critical intelligence solutions for national security. Its services include customer needs analysis, solution architecture definition, systems engineering, software development, product integration, ontology and data modeling and specialized training. The firm offers solutions for enhanced situational awareness, operational planning, intelligence and geospatial analysis and cyber and intelligence operations. The company was founded by Dean Alan Johnson in June 2005 and is headquartered in Hanover, MD. | Information Technology Services | Corporate Officer/Principal | |
| ADC THERAPEUTICS SA | Pharmaceuticals: Major | Director/Board Member | |
| G1 THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Life Science Holdings, Inc.
 Life Science Holdings, Inc. Pharmaceuticals: OtherHealth Technology Part of Sanofi, Life Science Holdings, Inc. is a company that manufactures white and private label cannabinoid products. The company is based in Swiftwater, PA. | Pharmaceuticals: Other | Director/Board Member | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin | |
| The Leonard N Stern School of Business | College/University | Masters Business Admin | |
Corvidia Therapeutics, Inc.
 Corvidia Therapeutics, Inc. BiotechnologyHealth Technology Corvidia Therapeutics, Inc. is a biotechnology company focusing on cardiovascular therapies. It develops treatments for atherosclerotic cardiovascular disease, inflammation in chronic kidney diseases, and high triglyceride-induced acute pancreatitis. The company was founded by Michael H. Davidson, Rahul Kakkar, Matt Devalaraja, and Ram Aiyar in 2015 and is headquartered in Waltham, MA. | Biotechnology | Director/Board Member | |
| CSTONE PHARMACEUTICALS | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| General Atlantic LLC (China) | Investment Managers | Corporate Officer/Principal | |
LifeMine Therapeutics, Inc.
 LifeMine Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology LifeMine Therapeutics, Inc. develops drugs from fungi which aims to cure untreatable and significant chronic diseases. The company was founded by Gregory L. Verdine, WeiQing Zhou, Richard D. Klausner and Hingge Hsu and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| WUXI BIOLOGICS (CAYMAN) INC. | Biotechnology | Director/Board Member Director/Board Member | |
Maryland Technology Council
 Maryland Technology Council Miscellaneous Commercial ServicesCommercial Services The Maryland Technology Council functions as a technology trade association. The private company is based in Rockville, MD. | Miscellaneous Commercial Services | Director/Board Member | |
Wuxi Biologics Holdings Ltd.
 Wuxi Biologics Holdings Ltd. Financial ConglomeratesFinance Wuxi Biologics Holdings Ltd. functions as an investment holding There is no available country named vg company. | Financial Conglomerates | Director/Board Member Director/Board Member | |
| ALPINE IMMUNE SCIENCES, INC. | Biotechnology | Director/Board Member | |
Antengene Corporation Co., Ltd.
 Antengene Corporation Co., Ltd. Pharmaceuticals: MajorHealth Technology Antengene Corporation Co., Ltd. operates as a holding company. It engages in clinical development of drug candidates. The company was founded on June 15, 2016 and is headquartered in Shanghai, China. | Pharmaceuticals: Major | Director/Board Member | |
Wuxi New Life Science Investment Ltd.
 Wuxi New Life Science Investment Ltd. Financial ConglomeratesFinance Wuxi New Life Science Investment Ltd. is a Chinese company that provides investment services. The private company is based in Shanghai, China. | Financial Conglomerates | Director/Board Member Director/Board Member | |
| Boyu Capital Group Management Ltd. | Corporate Officer/Principal | ||
Fujian Herui Gene Technology Co., Ltd.
 Fujian Herui Gene Technology Co., Ltd. BiotechnologyHealth Technology Fujian Herui Gene Technology Co. Ltd. provides biotechnological services. It mainly engages in the medical research & experimental development, biotechnology equipment leasing and medical testing services. The company was founded on August 17, 2017 and is headquartered in Fuzhou, China. | Biotechnology | Director/Board Member | |
| JW (CAYMAN) THERAPEUTICS CO. LTD | Biotechnology | Director/Board Member | |
| OCUMENSION THERAPEUTICS | Pharmaceuticals: Major | Director/Board Member | |
| HYGEIA HEALTHCARE HOLDINGS CO., LIMITED | Pharmaceuticals: Major | Director/Board Member | |
Sironax Ltd.
 Sironax Ltd. Pharmaceuticals: MajorHealth Technology Sironax Ltd. is a clinical-stage biotechnology company located in Beijing, China. The Chinese company is dedicated to discovering and developing novel treatments for patients with age-related degenerative diseases. Sironax has built a diverse pipeline of multiple programs, focusing on key mechanisms underlying age-related degenerative diseases including regulated cell death, neuroprotective pathways, and neuroinflammation. Currently, Sironax is conducting early clinical studies with sir0365 and sir2446, in addition to ongoing preclinical research. | Pharmaceuticals: Major | Chief Executive Officer | |
| ANTENGENE CORPORATION LIMITED | Pharmaceuticals: Major | Director/Board Member | |
VaxEquity Ltd.
 VaxEquity Ltd. BiotechnologyHealth Technology VaxEquity Ltd. is a UK biotechnology company founded in 2020 by Professor Robin Shattock, the head of immunology of infection at Imperial College and Morningside. The company is based in Little Chesterford, UK. The British company is developing transformative RNA therapeutics and vaccines using its next-generation self-amplifying RNA platform called SARNA. The platform provides extended duration of protein expression, enabling lower doses to be used for vaccines and higher protein levels to be achieved for therapeutics. VaxEquity is pioneering a next-generation approach by modifying its SARNA to modulate the innate immune response and thereby overcoming current limitations. The flexibility of the company's platform ensures that its broad pipeline of assets can be designed, developed, and manufactured rapidly and at scale. | Biotechnology | Director/Board Member | |
| VAXXINITY, INC. | Biotechnology | Human Resources Officer | |
| VENTYX BIOSCIENCES, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| Weill Cornell Medicine | College/University | Doctorate Degree |
Estadísticas
Internacional
| Estados Unidos | 25 |
| China | 14 |
| Reino Unido | 3 |
| Canadá | 3 |
| Hong-Kong | 3 |
Sectorial
| Health Technology | 29 |
| Consumer Services | 12 |
| Finance | 7 |
| Producer Manufacturing | 2 |
| Electronic Technology | 2 |
Operativa
| Director/Board Member | 70 |
| Corporate Officer/Principal | 19 |
| Independent Dir/Board Member | 12 |
| Undergraduate Degree | 8 |
| Chief Tech/Sci/R&D Officer | 7 |
Las relaciones más conectadas
| Insiders | |
|---|---|
| Edward Hu | 29 |
| Yan Ling Cao | 21 |
| Tyrell J. Rivers | 17 |
| Xiao Meng Tong | 15 |
| Wen Kai Xiang | 13 |
| Zheng Bin Yao | 11 |
| Jörn Drappa | 9 |
| Mitchell Chan | 6 |
| Kate Surdez | 6 |
| Aaron Ren | 5 |
| Carl Solomon | 4 |
| Soraya Madani | 1 |
- Bolsa de valores
- Insiders
- Matthew J. Pietras
- Conexiones Empresas
